Results 161 to 170 of about 403,304 (294)

Minimally Invasive Biological Gracilis Augmentation of Fascia Lata for Intra‐ and Extra‐articular Anterior Cruciate Ligament Reconstruction: XO FAST Technique

open access: yesArthroscopy Techniques, EarlyView.
Abstract The fascia lata (FL) is a long‐established and proven graft for anterior cruciate ligament reconstruction, allowing intra‐ and extra‐articular reconstruction to be combined with a single graft and a single femoral tunnel, without femoral fixation.
Pierre Denis‐Aubrée   +3 more
wiley   +1 more source

Hydroa Vacciniforme–Like Lymphoproliferative Disorder in the Elderly: A Case Report and Diagnostic Challenges

open access: yesInternational Medical Case Reports Journal
Xihan Long,1 Liyan Lai,1 Qiaomin Lin,1 Dejian Duan,2 Dan Huang,3 Muyuan Yu21The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, People’s Republic of China; 2Department of Dermatology, Shenzhen Bao’an Chinese ...
Long X   +5 more
doaj  

Indoor Tanning in Europe: Temporal Trends, Sociodemographic Determinants from the Euromelanoma Campaign (2009-2018). [PDF]

open access: yesCancers (Basel)
Gaeta A   +51 more
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

Correlation Between Serum 25-Hydroxyvitamin D Level and Demographic and Clinical Characteristics of Patients with Vitiligo: A Single-Center Retrospective Study

open access: yesClinical, Cosmetic and Investigational Dermatology
Weixin Zhang,1,* Jie Zhang,2,* Yue Shi31Department of Information Engineering, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People’s Republic of China; 2Department of Laboratory Medicine, Affiliated ...
Zhang W, Zhang J, Shi Y
doaj  

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden   +3 more
wiley   +1 more source

Intra-Patient Split-Lesion Comparison of Non-Cultured Epidermal Cell Suspension versus a Mechanically Processed Follicular Preparation in Stable Segmental Vitiligo: A Case Report

open access: yesClinical, Cosmetic and Investigational Dermatology
Huda ALQudah,1 Hanadi Qeyam,2 Yasmeen Alkatab,1 Wafaa Haddad11Department of Dermatology, Private Dermatology Clinic, Amman, Jordan; 2Department of Dermatology, Jordan University of Science and Technology, Irbid, JordanCorrespondence: Huda ALQudah, Email ...
ALQudah H, Qeyam H, Alkatab Y, Haddad W
doaj  

Cost‐effectiveness of DPYD genotyping prior to fluoropyrimidine‐based treatment for colorectal cancer in Wales

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Background Regulatory guidance in the United Kingdom advises DPYD genotyping prior to fluoropyrimidine‐based treatment. This economic evaluation estimated the costs and outcomes associated with DPYD screening prior to prescribing fluoropyrimidines for colorectal cancer in Wales and also considers additional variants to those included in ...
Catrin O. Plumpton   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy